Development Level

Tbio 78 | 11,445
Tdark 16 | 6,588
Tclin 8 | 613
Tchem 6 | 1,598

IMPC Phenotype

decreased vertical activity 2 | 208
increased circulating sodium l... 2 | 71
increased startle reflex 2 | 112
abnormal heart morphology 1 | 162
abnormal kidney morphology 1 | 65
abnormal lung morphology 1 | 26
abnormal seminal vesicle morph... 1 | 114
cardiovascular system phenotyp... 1 | 36
decreased T cell number 1 | 15
decreased circulating glucose ... 1 | 126
decreased lymphocyte cell numb... 1 | 83
decreased mature B cell number 1 | 7
decreased monocyte cell number 1 | 8
decreased prepulse inhibition 1 | 82
decreased red blood cell distr... 1 | 41
embryonic lethality prior to o... 1 | 239
embryonic lethality prior to t... 1 | 278
enlarged heart 1 | 210
hypoactivity 1 | 132
increased CD4-positive, alpha ... 1 | 4
increased erythrocyte cell num... 1 | 39
increased leukocyte cell numbe... 1 | 47
increased lymphocyte cell numb... 1 | 32
increased monocyte cell number 1 | 63
increased neutrophil cell numb... 1 | 46
polycystic kidney 1 | 15
preweaning lethality, incomple... 1 | 499
shortened RR interval 1 | 17

Disease

psoriasis 44 | 6,694
Carcinoma 41 | 11,493
lung cancer 41 | 4,740
ovarian cancer 40 | 8,520
Rheumatoid arthritis 39 | 1,191
invasive ductal carcinoma 33 | 2,951
lung carcinoma 31 | 2,843
diabetes mellitus 28 | 1,728
glioblastoma 28 | 5,792
non-small cell lung cancer 28 | 2,890
lung adenocarcinoma 27 | 2,716
Systemic lupus erythematosus 24 | 194
osteosarcoma 24 | 7,950
Cancer 23 | 2,499
Multiple Sclerosis 23 | 540
breast carcinoma 23 | 1,638
intraductal papillary-mucinous carcinoma (IPMC) 23 | 2,989
tuberculosis 23 | 2,010
Breast cancer 22 | 3,578
sarcoidosis 22 | 370
Astrocytoma, Pilocytic 21 | 3,081
malignant mesothelioma 20 | 3,232
cutaneous lupus erythematosus 19 | 1,057
intraductal papillary-mucinous neoplasm (IPMN) 19 | 3,291
pancreatic cancer 19 | 2,398
subependymal giant cell astrocytoma 19 | 2,287
ulcerative colitis 19 | 1,819
Berylliosis 17 | 28
Narcolepsy 17 | 72
cystic fibrosis 17 | 1,696
interstitial cystitis 17 | 2,312
medulloblastoma, large-cell 17 | 6,241
Hypersensitivity reaction type II disease 16 | 253
Schizophrenia 16 | 1,160
dermatomyositis 16 | 966
intraductal papillary-mucinous adenoma (IPMA) 16 | 2,955
pancreatic ductal adenocarcinoma liver metastasis 16 | 1,962
Autosomal recessive predisposition 15 | 1,442
atypical teratoid / rhabdoid tumor 15 | 5,112
Asthma 14 | 385
Multiple Sclerosis, Susceptibility to 14 | 15
Multiple myeloma 14 | 1,332
Narcolepsy-cataplexy 14 | 21
Vasculitis 14 | 80
colon cancer 14 | 1,478
ductal carcinoma in situ 14 | 1,745
group 3 medulloblastoma 14 | 4,104
Diffuse cutaneous systemic sclerosis 13 | 17
Hepatitis B 13 | 108
Rheumatoid Arthritis, Systemic Juvenile 13 | 16
Sarcoidosis 1 13 | 14
adrenocortical carcinoma 13 | 1,428
follicular lymphoma 13 | 20
juvenile dermatomyositis 13 | 1,187
limited scleroderma 13 | 19
Duchenne muscular dystrophy 12 | 601
Kidney disease 12 | 430
Liver Cirrhosis, Experimental 12 | 769
Type 1 diabetes mellitus 12 | 109
adult high grade glioma 12 | 3,801
Liver disease 11 | 237
Meningitis 11 | 67
Waldenstrons macroglobulinemia 11 | 765
Anemia 10 | 365
Immunologic Deficiency Syndromes 10 | 113
Lupus erythematosus 10 | 57
active Crohn's disease 10 | 922
acute quadriplegic myopathy 10 | 1,158
ependymoma 10 | 4,679
head and neck cancer and chronic obstructive pulmonary disease 10 | 239
limb girdle muscular dystrophy 2A 10 | 213
pancreatic carcinoma 10 | 562
periodontitis 10 | 293
primary Sjogren syndrome 10 | 735
Arthritis 9 | 290
Arthritis, Rheumatoid 9 | 174
Autoimmune Diseases 9 | 67
Becker muscular dystrophy 9 | 191
Inflammatory bowel disease 9 | 151
Lupus Erythematosus, Systemic 9 | 67
Melanoma 9 | 711
Thrombocytopenia 9 | 197
astrocytoma 9 | 1,146
esophageal adenocarcinoma 9 | 737
inflammatory breast cancer 9 | 286
non-small cell lung carcinoma 9 | 317
Connective tissue disease 8 | 62
Crohn's disease 8 | 321
Dermatitis 8 | 157
Down syndrome 8 | 499
Endometriosis 8 | 540
Hypersensitivity 8 | 63
Influenza 8 | 142
Juvenile rheumatoid arthritis 8 | 111
Malaria 8 | 160
Skin cancer 8 | 469
active ulcerative colitis 8 | 764
acute myeloid leukemia 8 | 783
hepatocellular carcinoma 8 | 547
pituitary cancer 8 | 1,972

Tissue

Endocrine System 91 | 18,159
Liver and Pancreas 90 | 16,750
Blood and immune system 89 | 16,909
Skin and soft tissues 89 | 17,230
Digestive Tract 88 | 17,369
Female tissues 88 | 17,400
Urinary Tract 87 | 16,678
Respiratory system 86 | 16,393
Male tissues 85 | 17,142
Cardiovascular System 81 | 15,192
Nervous System 81 | 16,725

Target Family

Non-IDG 103 | 12,091
Enzyme 3 | 4,145
Ion Channel 2 | 344

KEGG Pathway

Systemic lupus erythematosus 108 | 108
Metabolic pathways 1,263 | 1,263
Pathways in cancer 530 | 530
Olfactory transduction 414 | 414
Human papillomavirus infection 388 | 388
PI3K-Akt signaling pathway 349 | 349
HTLV-I infection 336 | 336
Endocytosis 310 | 310
MAPK signaling pathway 295 | 295
Epstein-Barr virus infection 280 | 280
Neuroactive ligand-receptor in... 276 | 276
Cytokine-cytokine receptor int... 267 | 267
Herpes simplex infection 262 | 262
Kaposi's sarcoma-associated he... 252 | 252
Viral carcinogenesis 251 | 251
Thermogenesis 232 | 232
Ras signaling pathway 230 | 230
Phagosome 229 | 229
Cellular senescence 228 | 228
Cell adhesion molecules (CAMs) 225 | 225
Rap1 signaling pathway 209 | 209
Regulation of actin cytoskelet... 207 | 207
cAMP signaling pathway 201 | 201
Focal adhesion 198 | 198
Proteoglycans in cancer 198 | 198
Natural killer cell mediated c... 197 | 197
Huntington's disease 194 | 194
Tuberculosis 189 | 189
Calcium signaling pathway 183 | 183
Chemokine signaling pathway 183 | 183
Influenza A 182 | 182
Axon guidance 174 | 174
Purine metabolism 172 | 172
Alzheimer's disease 171 | 171
Transcriptional misregulation ... 171 | 171
Tight junction 169 | 169
Hepatocellular carcinoma 168 | 168
NOD-like receptor signaling pa... 166 | 166
Protein processing in endoplas... 164 | 164
RNA transport 163 | 163
cGMP-PKG signaling pathway 162 | 162
Jak-STAT signaling pathway 161 | 161
Cushing's syndrome 158 | 158
Antigen processing and present... 156 | 156
Hippo signaling pathway 154 | 154
Necroptosis 154 | 154
Oxytocin signaling pathway 154 | 154
MicroRNAs in cancer 150 | 150
mTOR signaling pathway 150 | 150
Non-alcoholic fatty liver dise... 149 | 149
Gastric cancer 148 | 148
Retrograde endocannabinoid sig... 148 | 148
Adrenergic signaling in cardio... 147 | 147
Alcoholism 147 | 147
Breast cancer 147 | 147
Phospholipase D signaling path... 147 | 147
Wnt signaling pathway 145 | 145
Hepatitis B 143 | 143
Parkinson's disease 142 | 142
Estrogen signaling pathway 139 | 139
Apoptosis 138 | 138
Fluid shear stress and atheros... 138 | 138
Signaling pathways regulating ... 138 | 138
Insulin signaling pathway 137 | 137
Ubiquitin mediated proteolysis 137 | 137
Viral myocarditis 137 | 137
Apelin signaling pathway 136 | 136
Dopaminergic synapse 135 | 135
Ribosome 134 | 134
Measles 133 | 133
Oxidative phosphorylation 133 | 133
Relaxin signaling pathway 133 | 133
Spliceosome 132 | 132
Autoimmune thyroid disease 130 | 130
FoxO signaling pathway 130 | 130
Hepatitis C 130 | 130
Autophagy - animal 128 | 128
Osteoclast differentiation 127 | 127
Cell cycle 125 | 125
Platelet activation 125 | 125
Toxoplasmosis 125 | 125
Lysosome 123 | 123
Vascular smooth muscle contrac... 123 | 123
Type I diabetes mellitus 122 | 122
Oocyte meiosis 121 | 121
AMPK signaling pathway 120 | 120
Graft-versus-host disease 120 | 120
Neurotrophin signaling pathway 119 | 119
Th17 cell differentiation 119 | 119
Sphingolipid signaling pathway 118 | 118
Allograft rejection 116 | 116
Carbon metabolism 116 | 116
Glutamatergic synapse 116 | 116
Thyroid hormone signaling path... 116 | 116
Serotonergic synapse 114 | 114
Leukocyte transendothelial mig... 112 | 112
Cholinergic synapse 111 | 111
Hematopoietic cell lineage 108 | 108
TNF signaling pathway 108 | 108
Insulin resistance 107 | 107

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Histone H2A type 1-A HIST1H2AA Tbio Non-IDG -0.84480 8.19 69
Histone H2B type 1-N HIST1H2BN Tbio Non-IDG -1.51422 30.2 60
Histone H2B type 1-L HIST1H2BL Tdark Non-IDG 0.35 0.40 48
Complement C1q subcomponent subunit A C1QA Tbio Non-IDG -1.73823 51.2 241
Histone H2A type 1-B/E HIST1H2AB Tbio Non-IDG -1.27041 18.5 133
HLA class II histocompatibility antigen, DRB1-9 beta chain HLA-DRB1 Tbio Non-IDG 0.00000 0
Histone H2A.J H2AFJ Tdark Non-IDG -0.00172 0.83 99